Active Ingredient History

  • Now
Bucillamine is an antirheumatic agent developed from tiopronin. Activity is mediated by the two thiol groups that the molecule contains. Research done in USA showed positive transplant preservation properties. Bucillamine is currently being investigated for COVID-19 drug repurposing.   Wikipedia

  • SMILES: CC(C)(S)C(=O)N[C@H](CS)C(=O)O
  • Mol. Mass: 223.32
  • ALogP: 0.19
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
2-mercapto-2-methylpropanoyl-l-cysteine | bucillamine | l-cysteine, n-(2-mercapto-2-methyl-1-oxopropyl)- | n-(2-mercapto-2-methylpropionyl)-l-cysteine | rimatil | sa 96 | sa-96 | thiobutarit | tiobutarit


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue